# TW Equity Source Review Readiness Summary

Updated: 2026-06-06

Status: `tw_equity_source_review_readiness_summary_waiting_human_classification`.

## Purpose

This summary consolidates the TW equity source review line after the provider-specific terms apply runbook. It is a local-only readiness map for CEO/PM decisions. It does not approve source use, provider terms, source license, redistribution, retention, public display, derived-score use, SQL, Supabase connection, Supabase reads, Supabase writes, staging rows, production `daily_prices` mutation, TWSE source retrieval, market-data ingestion, source-derived row storage, public source promotion, row coverage points, or `scoreSource=real`.

## Completed Local-Only Artifacts

- `docs/TW_EQUITY_SOURCE_APPROVAL_DECISION_PACKET.md`
- `docs/TW_EQUITY_PROVIDER_SPECIFIC_TERMS_REVIEW_PACKET.md`
- `data/source-gates/tw-equity-provider-specific-terms-review-outcomes.json`
- `scripts/report-tw-equity-provider-specific-terms-review-outcome-ledger.mjs`
- `scripts/record-tw-equity-provider-specific-terms-review-outcome.mjs`
- `docs/TW_EQUITY_PROVIDER_SPECIFIC_TERMS_APPLY_RUNBOOK.md`
- `docs/reviews/TW_EQUITY_PROVIDER_SPECIFIC_TERMS_APPLY_RUNBOOK_ROLE_REVIEW_2026-06-06.md`

These artifacts are sufficient to receive a human classification and record it locally through the approved runbook. They are not sufficient to run a remote source, write data, or promote public runtime state.

## Current Blocking State

- Source approval remains `not_source_approved`.
- Provider-specific terms review outcome is not yet recorded.
- The outcome ledger still contains pending entries.
- The project is waiting for a specific human source/legal classification before any runbook apply step.
- Classification means one of the source/legal outcome classes, not the front-end category chips such as index, ETF, semiconductor, or IC design.

## Still Blocked

- Source approval.
- Provider terms approval.
- Source license approval.
- Redistribution approval.
- Retention approval.
- Public display approval.
- Derived-score use approval.
- SQL.
- Supabase connection, reads, or writes.
- Staging rows.
- Production `daily_prices` mutation.
- TWSE source retrieval.
- Market-data fetch, ingestion, or source-derived row storage.
- Public source promotion.
- Row coverage points.
- `scoreSource=real`.

## Safe Next Options

Option A: wait for a specific human classification and then use `docs/TW_EQUITY_PROVIDER_SPECIFIC_TERMS_APPLY_RUNBOOK.md` for exactly one local dry-run, one local apply, and immediate post-apply checks.

Option B: keep runtime/mock MVP hardening moving while the source/legal classification is pending.

Option C: prepare public readiness copy that says real-data preparation is in progress, without claiming source approval, provider approval, live data, professional signal quality, or real score readiness.

## CEO Recommendation

CEO recommends Option B now. The source review lane has reached a natural waiting point, so PM should not spend more engineering cycles expanding governance here until a specific human classification exists. The mainline should continue runtime/mock MVP hardening and public readability work, while A1/A2 can keep source review context maintained as support lanes.

## Stop Lines

Do not execute the apply runbook without a specific human classification.
Do not mutate the provider terms outcome ledger without the dry-run and apply sequence defined in the runbook.
Do not fetch market data.
Do not run SQL.
Do not connect to Supabase.
Do not write Supabase.
Do not create staging rows.
Do not mutate production `daily_prices`.
Do not promote `publicDataSource`.
Do not set `scoreSource=real`.
